- Home
- CCEL vs ALGS Comparison
CCEL vs ALGS Comparison
Compare CCEL & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- ALGS
- Stock Information
- Founded
- CCEL 1989
- ALGS 2018
- Country
- CCEL United States
- ALGS United States
- Employees
- CCEL N/A
- ALGS N/A
- Industry
- CCEL Managed Health Care
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- ALGS Health Care
- Exchange
- CCEL Nasdaq
- ALGS Nasdaq
- Market Cap
- CCEL 39.9M
- ALGS 36.0M
- IPO Year
- CCEL 1997
- ALGS 2020
- Fundamental
- Price
- CCEL $5.13
- ALGS $7.98
- Analyst Decision
- CCEL Strong Buy
- ALGS Strong Buy
- Analyst Count
- CCEL 1
- ALGS 1
- Target Price
- CCEL $8.50
- ALGS $70.00
- AVG Volume (30 Days)
- CCEL 8.3K
- ALGS 130.7K
- Earning Date
- CCEL 07-14-2025
- ALGS 08-05-2025
- Dividend Yield
- CCEL 7.97%
- ALGS N/A
- EPS Growth
- CCEL N/A
- ALGS N/A
- EPS
- CCEL 0.01
- ALGS N/A
- Revenue
- CCEL $32,102,750.00
- ALGS $3,270,000.00
- Revenue This Year
- CCEL $2.49
- ALGS N/A
- Revenue Next Year
- CCEL $0.95
- ALGS $51.55
- P/E Ratio
- CCEL $555.99
- ALGS N/A
- Revenue Growth
- CCEL 2.33
- ALGS N/A
- 52 Week Low
- CCEL $4.75
- ALGS $3.76
- 52 Week High
- CCEL $9.43
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CCEL 50.16
- ALGS 64.99
- Support Level
- CCEL $5.00
- ALGS $7.43
- Resistance Level
- CCEL $5.31
- ALGS $8.36
- Average True Range (ATR)
- CCEL 0.22
- ALGS 0.73
- MACD
- CCEL 0.02
- ALGS 0.20
- Stochastic Oscillator
- CCEL 43.09
- ALGS 94.08
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.